Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 21 Oct 2022 for Milestone Pharmaceuticals Inc., €82k. Read the official filing
Filing timeline
BuySaleMichael John Tomsicek
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-31.2%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Michael John Tomsicek: trading record in brief
Filings by Michael John Tomsicek span 2 companies, the busiest being CRISPR Therapeutics AG and Milestone Pharmaceuticals Inc. We count 2 filings; the first trade dates from 6 August 2021 and the latest from 19 October 2022.
Purchases make up the whole of the open-market record (1 purchase, €82k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 option exercise. So far in 2022, the count stands at 1 purchase and no sales.
On 21 October 2022 came the latest disclosure, an open-market purchase for €82k in Milestone Pharmaceuticals Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael John Tomsicek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
15,000 shares@ US$5.32100.0% of flowCommon SharesSEC:0001209191-22-054325:0
Canonical exit: 17 Jan 2023 (T+90)
25,000 shares@ US$17.75100.0% of flowCommon SharesSEC:0001209191-21-050719:0
2 of 2 declarations
